HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Condon, T. P. Articles by Bennett, C. F. Search for Related Content PubMed PubMed Citation Articles by Condon, T. P. Articles by Bennett, C. F. Social Bookmarking                      What's this?

Volume 271, Number 48, Issue of November 29, 1996 pp. 30398-30403
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Altered mRNA Splicing and Inhibition of Human E-selectin Expression by an Antisense Oligonucleotide in Human Umbilical Vein Endothelial Cells

(Received for publication, June 27, 1996, and in revised form, September 3, 1996)

From ISIS Pharmaceuticals, Department of Molecular Pharmacology, Carlsbad, California 92008

We have characterized the mechanism of action of an antisense oligodeoxynucleotide (ASO) targeting human endothelial leukocyte adhesion molecule, E-selectin. ISIS 4730, a 20-base ASO designed to be complementary to a region in the 3-untranslated region (3-UTR) of human E-selectin, is a potent and specific inhibitor of both mRNA and protein expression in human umbilical vein endothelial cells. Following treatment with ISIS 4730, a lower molecular weight mRNA (3300 bases) species was detected by Northern blot analysis with a corresponding decrease in the mature E-selectin transcript (3875 bases). The ASO-induced low molecular weight mRNA is stable and remains in the nucleus. We demonstrate that ISIS 4730 targets E-selectin pre-mRNA in the nucleus and promotes cleavage of the pre-mRNA at the hybridization site, resulting in prevention of splicing of the last intron. The change in molecular weight of the E-selectin transcript is the result of loss of the 3-UTR due to ASO-mediated RNA cleavage and retention of the last intron. Cleavage of the E-selectin pre-mRNA appears to be due to endogenous RNase H or a related enzyme activity.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. Hasselblatt, B. Hockenjos, C. Thoma, H. E. Blum, and W.-B. Offensperger Translation of stable hepadnaviral mRNA cleavage fragments induced by the action of phosphorothioate-modified antisense oligodeoxynucleotides Nucleic Acids Res., January 7, 2005; 33(1): 114 - 125. [Abstract] [Full Text] [PDF]

				J. Yano, K. Hirabayashi, S.-i. Nakagawa, T. Yamaguchi, M. Nogawa, I. Kashimori, H. Naito, H. Kitagawa, K. Ishiyama, T. Ohgi, et al. Antitumor Activity of Small Interfering RNA/Cationic Liposome Complex in Mouse Models of Cancer Clin. Cancer Res., November 15, 2004; 10(22): 7721 - 7726. [Abstract] [Full Text] [PDF]

				T. A. Vickers, S. Koo, C. F. Bennett, S. T. Crooke, N. M. Dean, and B. F. Baker Efficient Reduction of Target RNAs by Small Interfering RNA and RNase H-dependent Antisense Agents. A COMPARATIVE ANALYSIS J. Biol. Chem., February 21, 2003; 278(9): 7108 - 7118. [Abstract] [Full Text] [PDF]

				P. Sazani, S.-H. Kang, M. A. Maier, C. Wei, J. Dillman, J. Summerton, M. Manoharan, and R. Kole Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs Nucleic Acids Res., October 1, 2001; 29(19): 3965 - 3974. [Abstract] [Full Text] [PDF]

				J. G. Karras, R. A. McKay, N. M. Dean, and B. P. Monia Deletion of Individual Exons and Induction of Soluble Murine Interleukin-5 Receptor-alpha Chain Expression through Antisense Oligonucleotide-Mediated Redirection of Pre-mRNA Splicing Mol. Pharmacol., August 1, 2000; 58(2): 380 - 387. [Abstract] [Full Text]

				P. Lorenz, T. Misteli, B. F. Baker, C. F. Bennett, and D. L. Spector Nucleocytoplasmic shuttling: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides Nucleic Acids Res., January 15, 2000; 28(2): 582 - 592. [Abstract] [Full Text] [PDF]

				H. Zhang, R. Hanecak, V. Brown-Driver, R. Azad, B. Conklin, M. C. Fox, and K. P. Anderson Antisense Oligonucleotide Inhibition of Hepatitis C Virus (HCV) Gene Expression in Livers of Mice Infected with an HCV-Vaccinia Virus Recombinant Antimicrob. Agents Chemother., February 1, 1999; 43(2): 347 - 353. [Abstract] [Full Text]

				P. Lorenz, B. F. Baker, C. F. Bennett, and D. L. Spector Phosphorothioate Antisense Oligonucleotides Induce the Formation of Nuclear Bodies Mol. Biol. Cell, May 1, 1998; 9(5): 1007 - 1023. [Abstract] [Full Text]

				B. F. Baker, S. S. Lot, T. P. Condon, S. Cheng-Flournoy, E. A. Lesnik, H. M. Sasmor, and C. F. Bennett 2'-O-(2-Methoxy)ethyl-modified Anti-intercellular Adhesion Molecule 1 (ICAM-1) Oligonucleotides Selectively Increase the ICAM-1 mRNA Level and Inhibit Formation of the ICAM-1 Translation Initiation Complex in Human Umbilical Vein Endothelial Cells J. Biol. Chem., May 2, 1997; 272(18): 11994 - 12000. [Abstract] [Full Text] [PDF]